To get your young scholar off to a good start this school year, it’s important to make sure he or she is well-rested when the bell sounds, according to Reeba Mathew, M.D., a sleep expert with McGovern Medical School at The University of Texas of Health Science Center at Houston (UTHealth).
A four-protein biomarker blood test improves lung cancer risk assessment over existing guidelines that rely solely upon smoking history, capturing risk for people who have ever smoked, not only for heavy smokers, an international research team reports in JAMA Oncology. “This simple blood test demonstrates the potential of biomarker-based risk assessment to improve eligibility criteria for lung cancer screening with low-dose computed tomography,” said study co-senior author Sam Hanash, M.D., Ph.D., professor of Clinical Cancer Prevention at The University of Texas MD Anderson Cancer Center.
The operating rooms where Dr. Michael E. DeBakey and others performed the firsts in the heart surgery will close as the Houston Methodist DeBakey Heart & Vascular Center moves to a new high-tech building.
Enjoying full-fat milk, yogurt, cheese and butter is unlikely to send people to an early grave, according to new research by The University of Texas Health Science Center at Houston (UTHealth).
Richard Pollitt was at the end of his rope after years of suffering regular seizures, with some lasting five minutes and preventing him from working and enjoying his favorite pastimes. Desperate for relief after medications did not work, Pollitt had a small battery-powered device implanted in his skull to control seizures. Now he rarely has them.
Millennials living more dangerously and settling down later could be creating a new generation of addicted smokers and e-cigarette users, according to the surprising results of research by The University of Texas Health Science Center at Houston (UTHealth).
Beginning July 1, James M. Musser, M.D., Ph.D., becomes the 2018-2019 president of the Federation of American Societies for Experimental Biology (FASEB).
A guide to help battle a potentially fatal disease transferred by a blood-sucking insect called the kissing bug has been published by a task force led by The University of Texas Health Science Center at Houston (UTHealth).
A Houston Methodist program that provides specialty patient care to uninsured and underserved patients received another multi-million dollar gift from Occidental Petroleum Corporation.
The American Cancer Society's recent recommendations for changing the colorectal cancer screening age to 45 from age 50 had significant meaning for a Magnolia, Texas woman.
Targeted cancer therapy pioneer John Mendelsohn, M.D., researcher and former president of The University of Texas MD Anderson Cancer Center, will share the 2018 Tang Prize in Biopharmaceutical Science for his leadership in developing antibodies to block cancer-promoting growth factor receptors on the surface of cancer cells.
A study led by The University of Texas MD Anderson Cancer Center revealed that the investigational drug quizartinib prolonged overall survival for patients with a deadly form of acute myeloid leukemia (AML) linked to a genetic mutation called FMS-like internal tandem duplications (FLT3-ITD).
Using a targeted therapy to block a protein that suppresses T cell activity could improve cancer treatment with immune checkpoint inhibitors, researchers at The University of Texas MD Anderson Cancer Center report today in the Journal of Clinical Investigation.
Researchers at Houston Methodist Research Institute and The University of Texas MD Anderson Cancer Center have found a prescription drug, Calcitriol, approved by the Food and Drug Administration for the treatment of calcium deficiency and kidney diseases, may increase the likelihood of surviving ovarian cancer. Their preclinical research was reported in the Journal of the National Cancer Institute.
In a randomized, Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center, adding the PARP inhibitor veliparib to a standard chemotherapy agent improved overall response rates (ORR) in patients with small cell lung cancer (SCLC). Researchers also identified a select group of patients – those whose tumors expressed SLFN11— who also saw a progression-free survival (PFS) and overall survival (OS) benefit, suggesting a promising biomarker for the PARP-inhibitor sensitivity in SCLC.
A drug discovered and advanced by The University of Texas MD Anderson Cancer Center’s Institute for Applied Cancer Science (IACS) and the Center for Co-Clinical Trials (CCCT) inhibits a vital metabolic process required for cancer cells’ growth and survival.
When budding doctor Rebecca Thompson graduated from McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth) May 18, she furthered a four-generation-strong family legacy.
The University of Texas MD Anderson Cancer Center has named eight researchers to the third annual class of Andrew Sabin Family Fellows. As part of the Andrew Sabin Family Fellowship Program, each researcher will receive $100,000 in funding over two years. The Andrew Sabin Family Foundation established the program through a $30 million endowment to encourage creativity, innovation and highly impactful cancer research in four categories: basic science, clinical, physician-scientist, and population and quantitative science.
Recognizing that vaccination rates for the human papillomavirus (HPV) remain low across the U.S., particularly in Texas, The University of Texas MD Anderson Cancer Center again has joined with the 69 other National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement to call for increased HPV vaccination and evidence-based screening, with the goal of eliminating cancers caused by the virus.
The Houston Advanced Research Center (HARC) in The Woodlands, Texas has been awarded funding from the U.S. Department of Energy (DOE) to assist public and private entities considering Combined Heat and Power (CHP).
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right